Cas:100366-66-3 6,6′-Dibrom-2,2′:6′,2′-terpyridin manufacturer & supplier

Chemical Name:6,6′-Dibrom-2,2′:6′,2′-terpyridin

CAS.NO:100366-66-3

Synonyms:6,6”-Dibrom-2,2′:6′,2”-terpyridin;2,6”-dibromo-2,2′:6,2”-bipyridine;6,6′-dibromo-2,2′:6′,2”-terpyridine;2,2′:6′,2”-Terpyridine, 6,6”-dibromo-;MFCD01863557;6,6”-Dibromo-2,2′:6′,2”-terpyridine;2′,6-dibromo-2,2′:6′,6′-terpyridine

Molecular Formula:C₁₅H₉Br₂N₃

Molecular Weight:391.060

HS Code:2933399090

Physical and Chemical Properties:

Melting point:257-263ºC(lit.)

Boiling point:473.0±40.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.654

PSA:38.67000

Exact Mass:388.916321

LogP:3.55

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like 6,6”-Dibrom-2,2′:6′,2”-terpyridin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2′,6-dibromo-2,2′:6′,6′-terpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6”-dibromo-2,2′:6,2”-bipyridine Use and application,MFCD01863557 technical grade,usp/ep/jp grade.

Related News: “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2,5,11,14-tetraoxa-8-azoniabicyclo[13.4.0]nonadeca-1(19),15,17-triene manufacturers The CHMP has agreed on an update of recommendations for monitoring patients. Healthcare professionals should now check their patients for signs of blood cancers at least once a year for 15 years.1 6,8-dibromo-3-(2-bromoacetyl)chromen-2-one suppliers The vaccine has been through the ringer over safety worries before. In April, U.S. authorities halted its use and later tagged it with a warning over reports of rare blood clots occurring alongside bleeding in some recipients. (2S)-2-Oxiranylmethyl 4-nitrobenzoate vendor & factory The new R&D People and Culture Strategy aims to make UK the most ideal place for research and innovation, led by individuals, universities and businesses, and funders. ,“We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.”